Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal nephron morphology (HP:0012575)help
Grandparent Node:
expand
Abnormal renal corpuscle morphology (HP:0031263)help
Parent Node:
expand
Abnormal renal glomerulus morphology (HP:0000095)help
..Starting node
..expand
Glomerulopathy (HP:0100820)help
Term ID: 100820
Name: Glomerulopathy
Synonym: Diseased glomeruli
Definition: Inflammatory or noninflammatory diseases affecting the glomeruli of the nephron.
Comments:
Reference: HP:0100820
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal glomerular capillary morphology (HP:0025006) help
..expandAbnormal glomerular mesangium morphology (HP:0001966) help
..expandGlomerular basement membrane lamellation (HP:0030034) help
..expandGlomerular deposits (HP:0030949) help
..expandGlomerular endocapillary hypercellularity (HP:0025363) help
..expandGlomerular extracapillary hypercellularity (HP:0025364) help
..expandGlomerular sclerosis (HP:0000096) help
..expandGlomerulomegaly (HP:0030162) help
..expandGlomerulonephritis (HP:0000099) help
..expandLobular glomerulopathy (HP:0008636) help
..expandMultiple glomerular cysts (HP:0100611) help
..expandRenal juxtaglomerular cell hypertrophy/hyperplasia (HP:0000111) help
..expandThickened glomerular basement membrane (HP:0004722) help
..expandThin glomerular basement membrane (HP:0012577) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0100820HP:0100820Glomerulopathy0ACSL4 CL E G H21823571ORPHA:86818Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndromeHP:0040281 - Very frequent19
HP:0100820HP:0100820Glomerulopathy0AMMECR1 CL E G H9949467ORPHA:86818Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndromeHP:0040281 - Very frequent2
HP:0100820HP:0100820Glomerulopathy0APOE CL E G H348613OMIM:611771LIPOPROTEIN GLOMERULOPATHY; LPG39
HP:0100820HP:0100820Glomerulopathy0C4A CL E G H7201323ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0100820HP:0100820Glomerulopathy0CCR1 CL E G H12301602ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0100820HP:0100820Glomerulopathy0CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitisHP:0040281 - Very frequent10
HP:0100820HP:0100820Glomerulopathy0DNASE1L3 CL E G H17762959ORPHA:36412Hypocomplementemic urticarial vasculitisHP:0040282 - Frequent3
HP:0100820HP:0100820Glomerulopathy0ELP1 CL E G H85185959ORPHA:1764Familial dysautonomiaHP:0040283 - Occasional133
HP:0100820HP:0100820Glomerulopathy0ERAP1 CL E G H5175218173ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0100820HP:0100820Glomerulopathy0FAS CL E G H35511920ORPHA:117Behçet diseaseHP:0040283 - Occasional59
HP:0100820HP:0100820Glomerulopathy0FN1 CL E G H23353778ORPHA:84090Fibronectin glomerulopathyHP:0040281 - Very frequent9
HP:0100820HP:0100820Glomerulopathy0FOXC2 CL E G H23033801ORPHA:33001Lymphedema-distichiasis syndromeHP:0040283 - Occasional20
HP:0100820HP:0100820Glomerulopathy0GLA CL E G H27174296ORPHA:324Fabry diseaseHP:0040283 - Occasional291
HP:0100820HP:0100820Glomerulopathy0HLA-B CL E G H31064932ORPHA:117Behçet diseaseHP:0040283 - Occasional4
HP:0100820HP:0100820Glomerulopathy0HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitisHP:0040281 - Very frequent
HP:0100820HP:0100820Glomerulopathy0HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitisHP:0040281 - Very frequent1
HP:0100820HP:0100820Glomerulopathy0HNF1B CL E G H692811630ORPHA:93111HNF1B-related autosomal dominant tubulointerstitial kidney diseaseHP:0040283 - Occasional90
HP:0100820HP:0100820Glomerulopathy0IFNGR1 CL E G H34595439ORPHA:117Behçet diseaseHP:0040283 - Occasional60
HP:0100820HP:0100820Glomerulopathy0IL10 CL E G H35865962ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0100820HP:0100820Glomerulopathy0IL12A CL E G H35925969ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0100820HP:0100820Glomerulopathy0IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0100820HP:0100820Glomerulopathy0IL23R CL E G H14923319100ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0100820HP:0100820Glomerulopathy0KCNE5 CL E G H236306241ORPHA:86818Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndromeHP:0040281 - Very frequent5
HP:0100820HP:0100820Glomerulopathy0KLRC4 CL E G H83026377ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0100820HP:0100820Glomerulopathy0LMNA CL E G H40006636ORPHA:2348Familial partial lipodystrophy, Dunnigan typeHP:0040283 - Occasional645
HP:0100820HP:0100820Glomerulopathy0LMNB2 CL E G H848236638ORPHA:79087Acquired partial lipodystrophyHP:0040283 - Occasional11
HP:0100820HP:0100820Glomerulopathy0LMX1B CL E G H40106654ORPHA:2613Nail-patella-like renal diseaseHP:0040281 - Very frequent165
HP:0100820HP:0100820Glomerulopathy0LPIN2 CL E G H966314450ORPHA:77297Majeed syndromeHP:0040283 - Occasional186
HP:0100820HP:0100820Glomerulopathy0MEFV CL E G H42106998ORPHA:117Behçet diseaseHP:0040283 - Occasional281
HP:0100820HP:0100820Glomerulopathy0MMACHC CL E G H2597424525ORPHA:79282Methylmalonic acidemia with homocystinuria, type cblCHP:0040282 - Frequent101
HP:0100820HP:0100820Glomerulopathy0MTRR CL E G H45527473ORPHA:2169Methylcobalamin deficiency type cblEHP:0040283 - Occasional88
HP:0100820HP:0100820Glomerulopathy0OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of LoweHP:0040281 - Very frequent88
HP:0100820HP:0100820Glomerulopathy0PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitisHP:0040281 - Very frequent
HP:0100820HP:0100820Glomerulopathy0PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitisHP:0040281 - Very frequent3
HP:0100820HP:0100820Glomerulopathy0SCARB2 CL E G H9501665OMIM:254900Epilepsy, progressive myoclonic, 4, with or without renal failure.77
HP:0100820HP:0100820Glomerulopathy0STAT4 CL E G H677511365ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0100820HP:0100820Glomerulopathy0TLR4 CL E G H709911850ORPHA:117Behçet diseaseHP:0040283 - Occasional3
HP:0100820HP:0100820Glomerulopathy0TRNE CL E G H45567479ORPHA:225Maternally-inherited diabetes and deafnessHP:0040282 - Frequent
HP:0100820HP:0100820Glomerulopathy0TRNK CL E G H45667489ORPHA:225Maternally-inherited diabetes and deafnessHP:0040282 - Frequent
HP:0100820HP:0100820Glomerulopathy0TRNL1 CL E G H45677490ORPHA:225Maternally-inherited diabetes and deafnessHP:0040282 - Frequent
HP:0100820HP:0100820Glomerulopathy0UBAC2 CL E G H33786720486ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0100820HP:0100820Glomerulopathy0WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040283 - Occasional65
HP:0100820HP:0100820Glomerulopathy0WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040283 - Occasional6
HP:0100820HP:0100820Glomerulopathy0WT1 CL E G H749012796ORPHA:347Frasier syndromeHP:0040280 - Obligate177


Genes (44) :ACSL4 AMMECR1 APOE C4A CCR1 CTLA4 DNASE1L3 ELP1 ERAP1 FAS FN1 FOXC2 GLA HLA-B HLA-DPA1 HLA-DPB1 HNF1B IFNGR1 IL10 IL12A IL12A-AS1 IL23R KCNE5 KLRC4 LMNA LMNB2 LMX1B LPIN2 MEFV MMACHC MTRR OCRL PRTN3 PTPN22 SCARB2 STAT4 TLR4 TRNE TRNK TRNL1 UBAC2 WAS WIPF1 WT1

Diseases (21) :ORPHA:86818 OMIM:611771 ORPHA:117 ORPHA:900 ORPHA:36412 ORPHA:1764 ORPHA:84090 ORPHA:33001 ORPHA:324 ORPHA:93111 ORPHA:2348 ORPHA:79087 ORPHA:2613 ORPHA:77297 ORPHA:79282 ORPHA:2169 ORPHA:534 OMIM:254900 ORPHA:225 ORPHA:906 ORPHA:347
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.